Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 451.90
+11.75 (2.67%)
Jul 10, 2026, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 172.88 billion as of July 10, 2026. Its market cap has decreased by -54.39% in one year.
Market Cap
172.88B
Enterprise Value
174.85B
Revenue
22.69B
Ranking
n/a
PE Ratio
96.56
Stock Price
451.90
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 172.88B, an increase of 512,827.13%. That is a compound annual growth rate of 284.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 172.88B | -14.51% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 343.99B |
| Wockhardt | 294.22B |
| Piramal Pharma | 228.26B |
| Eris Lifesciences | 198.32B |
| NATCO Pharma | 176.26B |
| Alembic Pharmaceuticals | 164.60B |
| Alivus Life Sciences | 142.39B |
| Akums Drugs and Pharmaceuticals | 107.47B |